“Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s38. Accessed July 22, 2025. https://skin.dermsquared.com/skin/article/view/987.